by The Economist
My articles My siteMy videosMy books
Follow on:LinkedINTwitterFacebookYoutubeAmazonGoogle +
| What stories should you be following in 2023? From India becoming the world’s most populous country, to an illegal drug that might be approved as a medicine, The Economist offers its annual look at the year ahead. 00:00 - The World Ahead 2023 00:35 - India's population potential 04:30 - Psychedelic medicines 08:06 - Japan’s markets mayhem? 12:45 - Repairing the world 15:50 - The coronation's colonial concerns Read more on The World Ahead 2023: https://econ.st/3YyANzd Read Tom Standage’s editor’s note on The World Ahead 2023: https://econ.st/3WM5wY3 Sign up to The Economist’s daily newsletter: https://econ.st/3QAawvI Has China reached the peak of its powers? https://econ.st/3G3fgY8 India is continuing on its path to majoritarian chauvinism: https://econ.st/3jjZKOw Will China’s economy ever overtake America’s in size? https://econ.st/3v0p0Mn The Bank of Japan shocks investors: https://econ.st/3VkSbV8 Japan’s bond-market peg could snap: https://econ.st/3WiaVpT Repairing clothes is becoming more fashionable: https://econ.st/3YJfCud Ketamine, psilocybin and MDMA are coming to the medicine cabinet: https://econ.st/3W9G7aN More American clinics are offering ketamine to treat depression: https://econ.st/3G3cBO3 Sensible policy on psychedelic drugs is growing more common: https://econ.st/3jeiak2 Psychedelic therapy shows great promise. More states should legalise it: https://econ.st/3V9pfj0 King Charles III’s coronation is a real marketing opportunity: https://econ.st/3BMcAf1 |
The Economist offers authoritative insight and opinion on international news, politics, business, finance, science, technology and the connections between them.
Tags: Featured,newsletter
19 pings
Skip to comment form ↓